Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-14-032145
Filing Date
2014-05-19
Accepted
2014-05-19 17:00:51
Documents
1
Period of Report
2014-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v379121_6-k.htm 6-K 14326
  Complete submission text file 0001144204-14-032145.txt   15341
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 14855286
SIC: 2834 Pharmaceutical Preparations